When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XBIT - XBiotech commences mid-stage study of bermekimab in painful skin disorder
XBiotech Inc.
Enrollment is underway in a Phase 2 clinical trial evaluating XBiotech's (XBIT-0.3%) bermekimab in patients with hidradenitis suppurativa, a condition characterized by small painful lumps under the skin, typically in area where skin rubs together (e.g., armpits, groin, buttocks, breasts).
More news on: XBiotech Inc., Healthcare stocks news,